Featured Product
This Week in Quality Digest Live
FDA Compliance Features
Etienne Nichols
What’s the difference?
Liza Dzhezhora
How to ensure the integration of IoMT devices in your practice
Del Williams
Options to address the risk of combustible dust explosions for NFPA 61 compliance
Doug Folsom
Unpatched vulnerabilities will become increasingly susceptible to cyberattacks
Del Williams
Mitigate risk, prevent safety issues by utilizing closed conveyor systems designed with sanitation in mind

More Features

FDA Compliance News
Creates one of the most comprehensive regulatory SaaS platforms for the industry
Company’s first funding round will be used to accelerate product development for its QMS and MES SaaS offerings
Showcasing tech, solutions, and services at Gulfood Manufacturing 2022
Easy, reliable leak testing with methylene blue
Now is not the time to skip critical factory audits and supply chain assessments
Google Docs collaboration, more efficient management of quality deviations
Delivers time, cost, and efficiency savings while streamlining compliance activity
First trial module of learning tool focuses on ISO 9001 and is available now
Free education source for global medical device community

More News

Quality Digest

FDA Compliance

PhRMA Expands Campaign on Risks of Prescription Drug Importation

Published: Tuesday, July 26, 2005 - 22:00

The Pharmaceutical Research and Manufacturers of America recently launched an advertising campaign aimed at America’s senior citizens about the safety risks of importing prescription drugs from foreign countries. The campaign includes the launch of a new Web site, www.buysafedrugs.info, which acts a clearinghouse for information about prescription drug importation. PhRMA is advertising the site on search engines and blogs, and it has received 300,000 hits since its launch on June 21.

When politicians talk about importing drugs from Canada, they never tell you that the drugs, in reality, could be coming from countries like Pakistan, Thailand, South Africa, Latvia and Estonia,” says Ken Johnson, PhRMA senior vice president. “There’s a growing body of evidence that importation schemes threaten public health, and Americans need to understand the dangers associated with importation and learn about alternatives to taking these unnecessary risks.”

PhRMA’s new Web site also details safe, legal alternatives to importation and includes information about the pharmaceutical industry’s recently formed Partnership for Prescription Assistance, which matches those in need to programs that provide medicines for free or at reduced costs.

PhRMA represents research-based pharmaceutical and biotechnology companies in the United States.

For more information, visit www.buysafedrugs.info.


About The Author

Quality Digest’s picture

Quality Digest

For 40 years Quality Digest has been the go-to source for all things quality. Our newsletter, Quality Digest, shares expert commentary and relevant industry resources to assist our readers in their quest for continuous improvement. Our website includes every column and article from the newsletter since May 2009 as well as back issues of Quality Digest magazine to August 1995. We are committed to promoting a view wherein quality is not a niche, but an integral part of every phase of manufacturing and services.